A study finds distinct molecular changes in brain and spinal cord regions in ALS
Original source
A multi-omics characterization reveals distinct molecular signatures in the human motor cortex and lumbar spinal cord in ALS. (opens in a new tab)Compass summarised this from the study's abstract.
Study details
- Studied in
- Human
- Peer review
- Preprint, not yet peer reviewed
Population inferred from the title and abstract by Compass.
Researchers used spatial and single-nucleus gene-expression data from brain and spinal-cord tissue donated by people with amyotrophic lateral sclerosis (ALS) and non-neurological controls. ALS samples showed reduced motor-neuron and synaptic-signalling genes in the lumbar spinal cord, but layer-specific increases in synaptic signalling in the motor cortex. The molecular changes in the two regions were mostly different, and some spinal-cord changes varied with the site where symptoms began.
Why this matters
The findings suggest that ALS-related changes may differ between the motor cortex and lumbar spinal cord, and that symptom-onset site may influence some of those changes. This is laboratory research on donated human tissue and does not yet change treatment or establish that these molecular patterns cause disease progression.
Limitations and context
The source is a bioRxiv preprint listed as a journal article and preprint, so the work may not yet have completed peer review. The source does not provide the cohort size or enough detail here to assess the study population fully. The findings describe molecular patterns in tissue and would still need independent confirmation and links to clinical outcomes or treatment response.